Last updated: 13 August 2019 at 7:28am EST

Bruce Ross Net Worth




The estimated Net Worth of Bruce Ross is at least $2.69 Million dollars as of 24 August 2007. Bruce Ross owns over 6,250 units of Biogen Inc stock worth over $2,608,079 and over the last 21 years Bruce sold BIIB stock worth over $77,865.

Bruce Ross BIIB stock SEC Form 4 insiders trading

Bruce has made over 9 trades of the Biogen Inc stock since 2003, according to the Form 4 filled with the SEC. Most recently Bruce exercised 6,250 units of BIIB stock worth $230,875 on 24 August 2007.

The largest trade Bruce's ever made was exercising 25,000 units of Biogen Inc stock on 14 November 2003 worth over $116,750. On average, Bruce trades about 4,158 units every 73 days since 2003. As of 24 August 2007 Bruce still owns at least 13,100 units of Biogen Inc stock.

You can see the complete history of Bruce Ross stock trades at the bottom of the page.



What's Bruce Ross's mailing address?

Bruce's mailing address filed with the SEC is 3030 CALLAN RD, , SAN DIEGO, CA, 92121.

Insiders trading at Biogen Inc

Over the last 21 years, insiders at Biogen Inc have traded over $166,883,156 worth of Biogen Inc stock and bought 665,319 units worth $183,001,783 . The most active insiders traders include Adam Koppel, Alexander J Denner, and Stelios Papadopoulos. On average, Biogen Inc executives and independent directors trade stock every 10 days with the average trade being worth of $2,343,090. The most recent stock trade was executed by Priya Singhal on 30 August 2024, trading 1,668 units of BIIB stock currently worth $332,082.



What does Biogen Inc do?

through cutting-edge science and medicine, biogen discovers, develops and delivers innovative therapies worldwide for people living with serious neurological and neurodegenerative diseases. founded in 1978, biogen is a pioneer in biotechnology and today the company has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first and only approved treatment for spinal muscular atrophy, and is at the forefront of neurology research for conditions including alzheimer’s disease, parkinson’s disease and amyotrophic lateral sclerosis. biogen also manufactures and commercializes biosimilars of advanced biologics. with approximately 7000 people worldwide, we are truly a global organization, headquartered in cambridge, massachusetts, which is also home to our research operations. our international headquarters are based in zug, switzerland and we have world-class manufacturing facilities in north carolina and denmark. we offer therapies globally through direct affili



Complete history of Bruce Ross stock trades at Biogen Inc

Insider
Trans.
Transaction
Total value
Bruce Ross
Director
Option $230,875
24 Aug 2007
Bruce Ross
Director
Option $230,875
15 Aug 2007
Bruce Ross
Director
Option $171,700
25 Jul 2007
Bruce Ross
Director
Option $171,700
24 Jul 2007
Bruce Ross
Director
Sale $77,865
30 May 2007
Bruce Ross
Director
Option $233,100
22 Nov 2006
Bruce Ross
Director
Option $233,100
17 Nov 2006
Bruce Ross
Director
Option $466,200
19 Nov 2004
Bruce Ross
Director
Option $116,750
14 Nov 2003


Biogen Inc executives and stock owners

Biogen Inc executives and other stock owners filed with the SEC include: